The pharmaceutical company Mitelos, a member of Catalonia.health, announced an exclusive licensing and distribution agreement with East Midlands Pharma (EM Pharma), a leading UK distributor of consumer health and OTC medical products.

Under the terms of the agreement, EM Pharma is granted exclusive rights to market and distribute Mitelos’ clinically proven ear care solution, Otikeen®, across the United Kingdom and the Republic of Ireland. EM Pharma will launch the product under its established and recognizable consumer brand portfolio as Cl-ear Itchy Ears®. The launch of Cl-ear Itchy Ears® is expected to commence in Q4 2025, targeting pharmacies, independent retailers, and major national drugstore chains throughout the territory.

Joaquim Colomé, CEO of Mitelos, stated, “This partnership represents a significant step in our global expansion strategy. We sought a partner with deep market penetration and a consumer-focused approach, and EM Pharma, with their proven success in the UK and Ireland, is the perfect fit. Launching Otikeen® under the strong Cl-ear® brand will ensure this effective solution reaches the millions of people seeking reliable relief from ear discomfort, itching and dryness.”